Tablet
RAFALVO TABLETS 200MG
Summary
RAFALVO TABLETS 200MG — Tablet containing sorafenib (as tosilate). Hong Kong Registration No. HK-68075. Certificate Holder: LOTUS PHARMACEUTICAL HK LIMITED. Date of Registration: 13 Dec, 2023.
Product NameRAFALVO TABLETS 200MG
Registration No.HK-68075
Certificate HolderLOTUS PHARMACEUTICAL HK LIMITED
Holder Address2/F, JONSIM PLACE, NO.228 QUEEN'S ROAD EAST, WAN CHAI, HONG KONG
Ingredientssorafenib (as tosilate)
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration13 Dec, 2023
ATC codesL01EX02
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。